Introduction whether the functionally relevant substrate for ubiquitination is Gag itself or a cellular factor. HIV-1 p6 and HIV-1 assembly is driven by the viral Gag protein, which other retroviral Gag proteins are monoubiquitinated at is actively trafficked to the plasma membrane where it low levels (Ott et al., 2000) , and there is a general correlaassociates into enveloped, spherical particles that bud tion between Gag ubiquitination and virus release (Schufrom the cell (reviewed in Freed, 1998). During viral asbert et al., 2000b; Strack et al., 2000) . Moreover, the sembly, Gag is processed by the viral protease at a block imposed by proteasome inhibitors can be at least series of sites to produce four new structural proteins partially alleviated by covalently fusing Ub to the C-terthat perform essential functions in the mature, infectious minal end of Rous sarcoma virus (RSV) Gag (Patnaik et virion (denoted MA, CA, NC, and p6; Figure 1A) . Proteoal., 2000) . However, virus release and replication are not lytic processing is not required for particle production, affected by mutation of the two HIV-1 p6 lysine residues however, as HIV-1 Gag can assemble and bud in the (Lys-27 and Lys-33) that are the major sites for Gag absence of any other viral proteins.
ubiquitination (Ott et al., 2000) . The functional role of Gag The budding of an enveloped virus can be viewed as ubiquitination therefore remains uncertain. In principle, a fission event in which the continuous cell membrane is Gag ubiquitination could facilitate budding either by tarbroken and resealed to create discrete viral and cellular geting defective Gag molecules for proteolytic degradamembranes. Like other enveloped viruses, HIV-1 does tion and thereby preventing them from interfering with not encode its own membrane fission machinery, and viral budding (Schubert et al., 2000a) , or by creating presumably therefore must recruit and reprogram celludocking sites for cellular factors that actively participate lar proteins to assist in the budding process. A potential in viral budding. docking site for such a cellular factor(s) has been
To understand how HIV-1 and other enveloped viruses mapped to a conserved P(T/S)AP motif located in the bud, it is essential to define the participating cellular p6 domain of HIV-1 Gag. Point mutations within this factors. We now report that human tumor susceptibility "PTAP" motif arrest viral release at a very late stage gene 101 (Tsg101) is required for the release of infectious HIV-1 and suggest that the protein facilitates budding by linking the p6 late domain to vacuolar protein 4 Correspondence: wes@biochem.utah.edu 5 These authors contributed equally to this work.
sorting machinery. ). We independently used a similar strategy to screen for proteins that could cysteine residue required to make a transient thioester bond during ubiquitin transfer, and are presumably not bind to the PTAP late domain within HIV-1 p6 and obtained similar results. Briefly, HIV-1 NYU/BR5 p6 was used enzymatically active. A construct spanning Tsg101 residues 1-145 was used to characterize the interaction as bait to screen a human spleen cDNA prey library for potential binding partners. Genes encoding nearly fullbetween HIV-1 NL4-3 p6 and the Tsg101 UEV domain in vitro. Recombinant Tsg101 UEV was expressed in E. length Tsg101 were isolated twice, and were the only genes detected and confirmed in these screens. In subcoli, purified to homogeneity, and tested for binding to immobilized GST-p6 fusion proteins using a surface sequent experiments, we showed that full-length Tsg-101 bound wild-type p6 in directed two-hybrid liquid plasmon resonance biosensor (Figure 1 ). Tsg101 UEV exhibited concentration-dependent p6 binding, and culture assays, resulting in high levels of ␤-galactosidase activity (Ͼ300-fold over background; not shown).
equilibrium responses fit a simple 1:1 binding model with an equilibrium dissociation constant (K d
20ЊC
) of 27 Ϯ Three different p6 point mutants (P7L, A9R, and P10L) were used to test whether the Tsg101 binding interaction 5 M. As summarized in Figure 1A , a series of constructs spanning p6 residues 1-13, 1-27, 1-33, and 1-52 (fullrequired the PTAP motif within HIV-1 p6, and all three reduced ␤-galactosidase activity to background levels. length p6) all bound Tsg101 UEV with similar affinities. Thus, the primary Tsg101 binding site is located within Each of these point mutations also arrests HIV-1 budding at a late stage (Huang et al., 1995) . Hence, Tsg101 the first 13 residues of p6. Site-directed mutagenesis of p6 was then used to was judged an attractive candidate for the cellular factor that binds the PTAP late domain of HIV-1 p6 and facilimap the Tsg101 binding site more precisely. Residues 4-13 within full-length p6 were substituted individually tates viral budding.
Directed yeast two-hybrid experiments were further with alanine ( Figure 1E , dark bars) or with residues known to block virus release (light bars As the Vps4 mutants interfered with endosomal traftein had only modest effects (‫-3ف‬fold reduction). Similar results were obtained in the CEMss T cell line (data not ficking, we considered the possibility that particle release might have been inhibited by altered trafficking, shown). Thus, we conclude that HIV-1 requires both a PTAP motif and a functional Vps pathway to replicate activation, or assembly of viral proteins other than Gag (e.g., protease (PR), envelope (Env), or viral protein U).
in multiple cell types, including T cells. This was not the case, however, because the mutant GFP-Vps4 proteins also blocked release of viral con-A Functional Vps Pathway Is Required for Release of Infectious MLV from 293T Cells structs missing PR or Env (data not shown) and even blocked release of Gag-GFP alone ( Figure 4C, lanes 5 The effects of mutant GFP-Vps4 protein overexpression on MLV particle release and infectivity in 293T cells were and 6). As expected, Gag-GFP was released efficiently in the absence of the dominant negative Vps constructs, also tested ( Figure 5 ). In this case, virion-associated CA release was blocked, with a concomitant increase in but was blocked by mutation of the Gag p6 PTAP sequence (lane 3). These experiments demonstrate that cytoplasmic levels of the unprocessed Gag protein (lanes 5 and 6). Similarly, infectivity was dramatically the Vps4-induced block to HIV-1 release does not require any other viral proteins, consistent with the idea reduced (Ͼ800-fold for Vps4 E228Q ). Thus, the block to viral release imposed by the Vps4 mutants is more general that the p6 domain of the assembling Gag particle re-pathway (for both HIV-1 and MLV) participate in this final stage of viral particle release.
Discussion
Our experiments demonstrate a requirement for Tsg101 in HIV-1 budding. In summary, Tsg101 UEV binds specifically to the PTAP motif within p6 (VerPlank et al. (2001) and this work), and there is an excellent correlation between mutations that inhibit Tsg101 binding and those that inhibit virus release (Huang et al., 1995) . Depleting Tsg101 or inhibiting endosomal trafficking also arrests HIV-1 release at a late stage, indicating that Tsg101 and the Vps pathway perform essential functions in viral budding. Thus, these proteins represent potentially attractive new targets for therapeutic intervention.
The studies described herein also demonstrate the power of using the siRNA method developed by Tuschl and coworkers to test the functional requirement for a protein in a biological process (Elbashir et al., 2001). We have extended the utility of this technique by showing interactions, and analyze their biological functions.
(B) Mutant Vps4 proteins dominantly inhibit MLV replication. Samples were prepared as described in Figure 5A and MLV vector titers were quantitated as described in Experimental Procedures.
Protein Binding Motifs in Tsg101 UEV
We have shown that Tsg101 UEV is a multifunctional domain that can simultaneously bind both ubiquitin and than that imposed by depleting Tsg101, which appears the p6 PTAP motif, suggesting that Tsg101 may detect, to be HIV-specific. These observations indicate that late or possibly participate in, the Ub transfer event required endosomal trafficking, which is inhibited by the domifor HIV-1 budding. One attractive model is that ubiquitinant negative Vps4 proteins, is required for virus release nation of HIV-1 Gag during viral assembly creates high through both the PTAP and PPPY motifs. 
